| __timestamp | Ascendis Pharma A/S | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 49315000 |
| Thursday, January 1, 2015 | 9415000 | 75043000 |
| Friday, January 1, 2016 | 11504000 | 83749000 |
| Sunday, January 1, 2017 | 13482000 | 122682000 |
| Monday, January 1, 2018 | 25057000 | 207761000 |
| Tuesday, January 1, 2019 | 48473000 | 284812000 |
| Wednesday, January 1, 2020 | 76669000 | 317875000 |
| Friday, January 1, 2021 | 160180000 | 282660000 |
| Saturday, January 1, 2022 | 221227000 | 451421000 |
| Sunday, January 1, 2023 | 264410000 | 481871000 |
| Monday, January 1, 2024 | 284545000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Ascendis Pharma A/S from 2014 to 2023. Over this period, Sarepta consistently outspent Ascendis, with its SG&A expenses peaking at nearly double those of Ascendis in 2023. Notably, Sarepta's expenses grew by approximately 878% from 2014 to 2023, reflecting its aggressive expansion and investment in administrative capabilities. Meanwhile, Ascendis saw a staggering increase of over 4,100% in the same period, indicating rapid growth and scaling efforts. This data highlights the strategic financial decisions these companies make to maintain their competitive edge in the biotech industry. Understanding these trends can provide valuable insights into their operational strategies and market positioning.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
argenx SE or Ascendis Pharma A/S: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Sarepta Therapeutics, Inc. and CymaBay Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Ionis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Ascendis Pharma A/S and Grifols, S.A.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Alkermes plc
Ascendis Pharma A/S vs MannKind Corporation: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.